Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Management of Small Gallbladder Polyps

Size-Based Risk Assessment

  • Polyps ≤5-6mm have zero documented malignancy risk across multiple large studies, including a systematic review showing 0% malignancy in polyps <5mm and a survey of approximately 3 million gallbladder ultrasounds with no documented cancers in polyps <10mm at initial detection 1
  • The American College of Radiology and Society of Radiologists in Ultrasound establish intervention thresholds, and a 3mm polyp falls well below these thresholds 1
  • Up to 83% of apparent polyps ≤5mm are not even found at subsequent cholecystectomy, suggesting many represent imaging artifacts or transient findings 1

High-Risk Features

  • Primary sclerosing cholangitis is associated with a dramatically elevated 18-50% malignancy risk 4
  • The presence of specific high-risk features, such as sessile morphology, may warrant follow-up ultrasound at 6 months, 1 year, and 2 years 2

Future Imaging Considerations

  • No routine surveillance is needed for a 3mm polyp, but future imaging would be warranted if the patient develops biliary symptoms or if incidental imaging shows the polyp has grown to ≥10mm 2
  • If future imaging shows growth to ≥10mm, surgical consultation becomes appropriate 2